A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels with a Noninvasive Blood Biomarker of Mucosal Remission

Anas Gremida; Parakkal Deepak

doi:10.1093/crocol/otab036

A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels with a Noninvasive Blood Biomarker of Mucosal Remission

Research output: Contribution to journal › Editorial

Original language	English
Article number	otab036
Journal	Crohn's and Colitis 360
Volume	3
Issue number	3
DOIs	https://doi.org/10.1093/crocol/otab036
State	Published - Jul 1 2021

Access to Document

10.1093/crocol/otab036

Cite this

@article{a43aa4e8a09a4b81a21cab82d7dcd808,

title = "A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels with a Noninvasive Blood Biomarker of Mucosal Remission",

author = "Anas Gremida and Parakkal Deepak",

year = "2021",

month = jul,

day = "1",

doi = "10.1093/crocol/otab036",

language = "English",

volume = "3",

journal = "Crohn's and Colitis 360",

issn = "2631-827X",

number = "3",

}

TY - JOUR

T1 - A New Way to Assess the Trajectory of Remission in Crohn Disease

T2 - Correlating Drug Levels with a Noninvasive Blood Biomarker of Mucosal Remission

AU - Gremida, Anas

AU - Deepak, Parakkal

PY - 2021/7/1

Y1 - 2021/7/1

UR - http://www.scopus.com/inward/record.url?scp=85114157510&partnerID=8YFLogxK

U2 - 10.1093/crocol/otab036

DO - 10.1093/crocol/otab036

M3 - Editorial

AN - SCOPUS:85114157510

SN - 2631-827X

VL - 3

JO - Crohn's and Colitis 360

JF - Crohn's and Colitis 360

IS - 3

M1 - otab036

ER -

A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels with a Noninvasive Blood Biomarker of Mucosal Remission

Access to Document

Other files and links

Cite this